The Role of Technology in Modern Trials

The Role of Technology in Modern Trials With the changing times of court trials, technology has become an integral part of contemporary trials. Right from case preparation to presentation in the courtroom, technology is crucial in determining the way trials are being held. The use of digital media has not only speeded up the trials

... Continue Reading.

Cambodian Minister Dith Tina Emphasizes IP Registration

Cambodian Minister Dith Tina Emphasizes IP Registration Urges more development and value-added processing to increase the country’s agricultural products Dith Tina, Cambodia’s Minister of Agriculture, Forestry and Fisheries, has emphasized the significance of intellectual property (IP) registration in raising the value of Cambodian agricultural goods. He was speaking at the extended celebrations of World Intellectual

... Continue Reading.

Gibson Dunn Advised The Underwriters In UPS’s $4 billion And $170 Million Senior Notes Offerings

Gibson Dunn advised the underwriters in UPS’s $4 billion and $170 million senior notes offerings Gibson Dunn advised the underwriters in United Parcel Service’s (UPS) $4 billion offering of senior notes, comprising: $500 million 4.650% senior notes due 2030 $1.25 billion 5.250% senior notes due 2035 $1.25 billion 5.950% senior notes due 2055 $1 billion

... Continue Reading.

S&R Associates Represented Bertelsmann India Investments In USD 21 Million Series B Investment In CureBay Technologies

S&R Associates represented Bertelsmann India Investments in USD 21 Million Series B Investment in CureBay Technologies S&R Associates represented Bertelsmann India Investments in its lead investment in CureBay Technologies, a technology-enabled hybrid healthcare platform, as part of a USD 21 million Series B funding round. The round also involved British International Investment and Elevar Equity.

... Continue Reading.

Akin Advised Pharmakon On Its Debt Financing For Optinose’s Sale To Paratek Pharmaceuticals

Akin advised Pharmakon on its debt financing for Optinose’s sale to Paratek Pharmaceuticals Akin advised Pharmakon Advisors, LP and its investment funds in providing, alongside other lenders including funds managed by Oaktree Capital Management, L.P., debt financing for the acquisition of Optinose, Inc. and its product, XHANCE® (fluticasone propionate), by Paratek Pharmaceuticals, Inc., a privately

... Continue Reading.